Exact Mass: 563.3108

Exact Mass Matches: 563.3108

Found 51 metabolites which its exact mass value is equals to given mass value 563.3108, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Dihydroergocornine

N-[2-hydroxy-5,8-dioxo-4,7-bis(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carboxamide

C31H41N5O5 (563.3108)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Phe Ile Val Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Ile Trp Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Leu Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Leu Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Val Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Phe Trp Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Ile Phe Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Ile Phe Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Ile Val Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Ile Val Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Ile Trp Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Ile Trp Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Leu Phe Val Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Leu Phe Trp Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Leu Val Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Leu Val Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Leu Trp Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Leu Trp Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Ile Trp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Leu Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Trp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Phe Trp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Ile Phe Trp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Ile Trp Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Leu Phe Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C31H41N5O5 (563.3108)


   

Val Leu Trp Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Val Trp Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C31H41N5O5 (563.3108)


   

Trp Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Trp Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C31H41N5O5 (563.3108)


   

Dihydroergocornine

Dihydroergocornine

C31H41N5O5 (563.3108)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Ergocornine in which a single bond replaces the double bond between positions 9 and 10. C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

(4s)-n-{2-hydroxy-4,7-diisopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl}-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,12(16),13-tetraene-4-carboximidic acid

(4s)-n-{2-hydroxy-4,7-diisopropyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl}-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(15),2,12(16),13-tetraene-4-carboximidic acid

C31H41N5O5 (563.3108)